New

Antidiabetic Thiazolidinediones Market

2021

Antidiabetic Thiazolidinediones Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Rosiglitazone, Pioglitazone); End User (Hospital, Clinic, Others ), and Geography

| Report Code: TIPRE00021679 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Antidiabetic Thiazolidinediones Market 2028 By Type, End User, and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Thiazolidinediones, also known as glitazones, are a type of medication that can be used to treat type 2 diabetes. They're a kind of hypoglycemic medication that's taken orally.

MARKET DYNAMICS

The antidiabetic thiazolidinediones market is driving due to the rising prevalence of diabetes and rising geriatric population. However, presence of other diabetes medicines is expected to hamper the growth of the global antidiabetic thiazolidinediones market.

MARKET SCOPE

The "Antidiabetic Thiazolidinediones Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of antidiabetic thiazolidinediones market with detailed market segmentation by end user and type. The antidiabetic thiazolidinediones market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in antidiabetic thiazolidinediones market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The antidiabetic thiazolidinediones market is segmented on the basis of type and end user. Based on type, the market is segmented as rosiglitazone and pioglitazone. On the basis of end user, the market is categorized as hospital, clinic, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Antidiabetic thiazolidinediones market based on various segments. It also provides market size and forecast estimates from year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Antidiabetic thiazolidinediones market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Antidiabetic thiazolidinediones market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Antidiabetic thiazolidinediones market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Antidiabetic thiazolidinediones market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Antidiabetic thiazolidinediones market are anticipated to have lucrative growth opportunities in the future with the rising demand for Antidiabetic thiazolidinediones in the global market. Below mentioned is the list of few companies engaged in the Antidiabetic thiazolidinediones market.

The report also includes the profiles of key players in Antidiabetic thiazolidinediones market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Bristol-Myers Squibb
  •   Pfizer
  •   Boehringer Ingelheim
  •   Eli Lilly
  •   Merck and Co.
  •   AstraZeneca
  •   GlaxoSmithKline
  •   Sanofi
  •   Takeda Pharmaceuticals
  •   Novo Nordisk

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Antidiabetic Thiazolidinediones Market - By Type
1.3.2 Antidiabetic Thiazolidinediones Market - By End User
1.3.3 Antidiabetic Thiazolidinediones Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANTIDIABETIC THIAZOLIDINEDIONES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTIDIABETIC THIAZOLIDINEDIONES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANTIDIABETIC THIAZOLIDINEDIONES MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTIDIABETIC THIAZOLIDINEDIONES - GLOBAL MARKET OVERVIEW
6.2. ANTIDIABETIC THIAZOLIDINEDIONES - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTIDIABETIC THIAZOLIDINEDIONES MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. ROSIGLITAZONE
7.3.1. Overview
7.3.2. Rosiglitazone Market Forecast and Analysis
7.4. PIOGLITAZONE
7.4.1. Overview
7.4.2. Pioglitazone Market Forecast and Analysis
8. ANTIDIABETIC THIAZOLIDINEDIONES MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL
8.3.1. Overview
8.3.2. Hospital Market Forecast and Analysis
8.4. CLINIC
8.4.1. Overview
8.4.2. Clinic Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. ANTIDIABETIC THIAZOLIDINEDIONES MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Antidiabetic Thiazolidinediones Market Overview
9.1.2 North America Antidiabetic Thiazolidinediones Market Forecasts and Analysis
9.1.3 North America Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By Type
9.1.4 North America Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By End User
9.1.5 North America Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By Countries
9.1.5.1 United States Antidiabetic Thiazolidinediones Market
9.1.5.1.1 United States Antidiabetic Thiazolidinediones Market by Type
9.1.5.1.2 United States Antidiabetic Thiazolidinediones Market by End User
9.1.5.2 Canada Antidiabetic Thiazolidinediones Market
9.1.5.2.1 Canada Antidiabetic Thiazolidinediones Market by Type
9.1.5.2.2 Canada Antidiabetic Thiazolidinediones Market by End User
9.1.5.3 Mexico Antidiabetic Thiazolidinediones Market
9.1.5.3.1 Mexico Antidiabetic Thiazolidinediones Market by Type
9.1.5.3.2 Mexico Antidiabetic Thiazolidinediones Market by End User
9.2. EUROPE
9.2.1 Europe Antidiabetic Thiazolidinediones Market Overview
9.2.2 Europe Antidiabetic Thiazolidinediones Market Forecasts and Analysis
9.2.3 Europe Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By Type
9.2.4 Europe Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By End User
9.2.5 Europe Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Antidiabetic Thiazolidinediones Market
9.2.5.1.1 Germany Antidiabetic Thiazolidinediones Market by Type
9.2.5.1.2 Germany Antidiabetic Thiazolidinediones Market by End User
9.2.5.2 France Antidiabetic Thiazolidinediones Market
9.2.5.2.1 France Antidiabetic Thiazolidinediones Market by Type
9.2.5.2.2 France Antidiabetic Thiazolidinediones Market by End User
9.2.5.3 Italy Antidiabetic Thiazolidinediones Market
9.2.5.3.1 Italy Antidiabetic Thiazolidinediones Market by Type
9.2.5.3.2 Italy Antidiabetic Thiazolidinediones Market by End User
9.2.5.4 Spain Antidiabetic Thiazolidinediones Market
9.2.5.4.1 Spain Antidiabetic Thiazolidinediones Market by Type
9.2.5.4.2 Spain Antidiabetic Thiazolidinediones Market by End User
9.2.5.5 United Kingdom Antidiabetic Thiazolidinediones Market
9.2.5.5.1 United Kingdom Antidiabetic Thiazolidinediones Market by Type
9.2.5.5.2 United Kingdom Antidiabetic Thiazolidinediones Market by End User
9.2.5.6 Rest of Europe Antidiabetic Thiazolidinediones Market
9.2.5.6.1 Rest of Europe Antidiabetic Thiazolidinediones Market by Type
9.2.5.6.2 Rest of Europe Antidiabetic Thiazolidinediones Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Antidiabetic Thiazolidinediones Market Overview
9.3.2 Asia-Pacific Antidiabetic Thiazolidinediones Market Forecasts and Analysis
9.3.3 Asia-Pacific Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Antidiabetic Thiazolidinediones Market
9.3.5.1.1 Australia Antidiabetic Thiazolidinediones Market by Type
9.3.5.1.2 Australia Antidiabetic Thiazolidinediones Market by End User
9.3.5.2 China Antidiabetic Thiazolidinediones Market
9.3.5.2.1 China Antidiabetic Thiazolidinediones Market by Type
9.3.5.2.2 China Antidiabetic Thiazolidinediones Market by End User
9.3.5.3 India Antidiabetic Thiazolidinediones Market
9.3.5.3.1 India Antidiabetic Thiazolidinediones Market by Type
9.3.5.3.2 India Antidiabetic Thiazolidinediones Market by End User
9.3.5.4 Japan Antidiabetic Thiazolidinediones Market
9.3.5.4.1 Japan Antidiabetic Thiazolidinediones Market by Type
9.3.5.4.2 Japan Antidiabetic Thiazolidinediones Market by End User
9.3.5.5 South Korea Antidiabetic Thiazolidinediones Market
9.3.5.5.1 South Korea Antidiabetic Thiazolidinediones Market by Type
9.3.5.5.2 South Korea Antidiabetic Thiazolidinediones Market by End User
9.3.5.6 Rest of Asia-Pacific Antidiabetic Thiazolidinediones Market
9.3.5.6.1 Rest of Asia-Pacific Antidiabetic Thiazolidinediones Market by Type
9.3.5.6.2 Rest of Asia-Pacific Antidiabetic Thiazolidinediones Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Antidiabetic Thiazolidinediones Market Overview
9.4.2 Middle East and Africa Antidiabetic Thiazolidinediones Market Forecasts and Analysis
9.4.3 Middle East and Africa Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Antidiabetic Thiazolidinediones Market
9.4.5.1.1 South Africa Antidiabetic Thiazolidinediones Market by Type
9.4.5.1.2 South Africa Antidiabetic Thiazolidinediones Market by End User
9.4.5.2 Saudi Arabia Antidiabetic Thiazolidinediones Market
9.4.5.2.1 Saudi Arabia Antidiabetic Thiazolidinediones Market by Type
9.4.5.2.2 Saudi Arabia Antidiabetic Thiazolidinediones Market by End User
9.4.5.3 U.A.E Antidiabetic Thiazolidinediones Market
9.4.5.3.1 U.A.E Antidiabetic Thiazolidinediones Market by Type
9.4.5.3.2 U.A.E Antidiabetic Thiazolidinediones Market by End User
9.4.5.4 Rest of Middle East and Africa Antidiabetic Thiazolidinediones Market
9.4.5.4.1 Rest of Middle East and Africa Antidiabetic Thiazolidinediones Market by Type
9.4.5.4.2 Rest of Middle East and Africa Antidiabetic Thiazolidinediones Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Antidiabetic Thiazolidinediones Market Overview
9.5.2 South and Central America Antidiabetic Thiazolidinediones Market Forecasts and Analysis
9.5.3 South and Central America Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By Type
9.5.4 South and Central America Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By End User
9.5.5 South and Central America Antidiabetic Thiazolidinediones Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Antidiabetic Thiazolidinediones Market
9.5.5.1.1 Brazil Antidiabetic Thiazolidinediones Market by Type
9.5.5.1.2 Brazil Antidiabetic Thiazolidinediones Market by End User
9.5.5.2 Argentina Antidiabetic Thiazolidinediones Market
9.5.5.2.1 Argentina Antidiabetic Thiazolidinediones Market by Type
9.5.5.2.2 Argentina Antidiabetic Thiazolidinediones Market by End User
9.5.5.3 Rest of South and Central America Antidiabetic Thiazolidinediones Market
9.5.5.3.1 Rest of South and Central America Antidiabetic Thiazolidinediones Market by Type
9.5.5.3.2 Rest of South and Central America Antidiabetic Thiazolidinediones Market by End User
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ANTIDIABETIC THIAZOLIDINEDIONES MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ANTIDIABETIC THIAZOLIDINEDIONES MARKET, KEY COMPANY PROFILES
12.1. BRISTOL-MYERS SQUIBB
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. PFIZER
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BOEHRINGER INGELHEIM
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ELI LILLY
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MERCK AND CO.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ASTRAZENECA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. GLAXOSMITHKLINE
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SANOFI
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. TAKEDA PHARMACEUTICALS
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. NOVO NORDISK
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Bristol-Myers Squibb
2. Pfizer
3. Boehringer Ingelheim
4. Eli Lilly
5. Merck and Co.
6. AstraZeneca
7. GlaxoSmithKline
8. Sanofi
9. Takeda Pharmaceuticals
10. Novo Nordisk
11. Mylan Pharmaceuticals Inc.
12. Teva Pharmaceuticals USA, Inc.
13. Aurobindo Pharma Limited
14. Solco Healthcare U.S., LLC
15. Macleods Pharmaceuticals Limited
16. PuraCap Pharmaceutical LLC
TIPRE00021679
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.